First Command Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

First Command Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$21.1K	Sell	60 -15	-20%	-$5.05K	﹤0.01%	298
2023 Q1	$23.6K	Hold	75	–	–	﹤0.01%	284
2022 Q4	$22K	Hold	75	–	–	﹤0.01%	281
2022 Q3	$22K	Sell	75 -25	-25%	-$7.19K	﹤0.01%	279
2022 Q2	$28K	Hold	100	–	–	﹤0.01%	270
2022 Q1	$26K	Hold	100	–	–	﹤0.01%	286
2021 Q4	$18K	Hold	100	–	–	﹤0.01%	329
2021 Q3	$18K	Hold	100	–	–	﹤0.01%	329
2021 Q2	$20K	Hold	100	–	–	﹤0.01%	322
2021 Q1	$21K	Hold	100	–	–	﹤0.01%	300
2020 Q4	$24K	Hold	100	–	–	0.01%	255
2020 Q3	$27K	Hold	100	–	–	0.01%	225
2020 Q2	$29K	Hold	100	–	–	0.01%	220
2020 Q1	$24K	Hold	100	–	–	0.01%	224
2019 Q4	$22K	Hold	100	–	–	0.01%	261
2019 Q3	$17K	Buy	+100	New	+$17.7K	0.01%	280

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Command Bank's VRTX Position: Q2 2023 in Review

First Command Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2023, selling an estimated $5.05K and leaving 60 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

First Command Bank first reported a position in VRTX in Q3 2019 and has held it in 16 quarters since. The position peaked at $29K in Q2 2020. 1,285 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

First Command Bank held 60 shares of Vertex Pharmaceuticals worth $21.1K as of Q2 2023.
First Command Bank sold 15 Vertex Pharmaceuticals shares in Q2 2023, an estimated $5.05K.
Vertex Pharmaceuticals made up ﹤0.01% of First Command Bank's portfolio in Q2 2023, its #298 holding.
First Command Bank first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 16 quarters since.
First Command Bank's Vertex Pharmaceuticals position peaked at $29K in Q2 2020.
1,285 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on First Command Bank's 13F filing for Q2 2023, filed 21 Jul 2023.